Urinary peritonitis caused by gangrenous cystitis
1Medical Intensive Care Unit, Ibn Rochd University Hospital
DOI: 10.22514/SV32.102008.3 Vol.3,Issue 2,October 2008 pp.32-33
Published: 01 October 2008
*Corresponding Author(s): SAID MOTAOUAKKIL E-mail: firstname.lastname@example.org
We report a case of a young man who developed severe urinary sepsis, on the 21st day of hospitalization (DH), which was treated with ciprofloxacin and gentamicin. On the 30th DH, he developed bloodstream and urinary infections due to Acinetobacter baumannii which had been treated with colistin and rifampicin. On the 55th DH, he developed urinary peritonitis and necrosis of the anterior and posterior bladder wall. Bilateral ureterostomy was performed. The patient was treated with colistin and imipenem. Peritoneal fluid culture yielded Enterobacter cloacae susceptible to imipenem. An enterocystoplasty was performed. The outcome was favourable.
peritonitis, Acinetobacter baumannii, colistin, rifampicin
BOUBAKER CHARRA,ABDELHAMID HACHIMI,MUSTAPHA SODKI,HOUDA GUEDDARI,ABDELLATIF BENSLAMA,SAID MOTAOUAKKIL. Urinary peritonitis caused by gangrenous cystitis. Signa Vitae. 2008. 3(2);32-33.
1. Striling WC, Hopkins GA. Gangrene of the bladder. Review of 207 cases and report of 2 personal cases. J Urol 1934;3:517-25.
2. Bragança N, Cruz T, Fonseca J, Faria M, Partidário J. Gangrenous cystitis. Acta Med Port 2001 May-Jun;14(3):357-9.
3. Raza A, Balsitis M, Hosie KB. Gangrenous cystitis: a rare cause of colovesical fistula. Postgrad Med J 1999;75:34-5.
4. Pollard SG. Colovesical fistula. Ann R Coll Surg 1987;69:163–5.
5. Devitt AT, Sethia KK. Gangrenous cystitis. Case report and review of the literature. J Urol 1993;149:1544-5.
Vol., Issue , Invalid dateTable of contents
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.